AVP BioPharma Consult ApS: Financial statements 2017
CVR: 37770426
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,089,445 and a net result of DKK 57,529. Equity in the 2017 report amounted to DKK 142,257. The solvency ratio was 52.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,089,445
- Profit/Loss
- DKK 57,529
- Equity
- DKK 142,257
- Total Assets
- DKK 272,913
- Employees
- 1
Official annual report
Keep an eye on AVP BioPharma Consult ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
AVP BioPharma Consult ApS has published its interim report for the period June 1, 2016 to December 31, 2016.
About AVP BioPharma Consult ApS
AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.